NRNP 6512 Comprehensive Case Study Exam Prep
Document | 2026/2027 Edition | 200 Verified Questions
NRNP 6512 Week 7 Comprehensive Case Study: 57-Year-Old Patient with High Blood Pressure - 2026-2027
Questions and Answers Already Graded A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for advanced practice
nursing students enrolled in NRNP 6512. It focuses on a detailed case study of a 57-year-old patient
presenting with high blood pressure, encompassing the complete Health History and Physical (H&P),
differential diagnosis, and a comprehensive management plan. With 200 verified questions, this
resource mirrors the actual exam format and content, ensuring students are thoroughly prepared to
achieve a 100% expert score. Updated for the 2026/2027 academic year, it reflects the latest clinical
guidelines and best practices in primary care.
Key Features:
Complete Health History and Physical (H&P) documentation
Differential diagnosis and diagnostic reasoning
Evidence-based management plan for hypertension
Pharmacological and non-pharmacological interventions
Patient education and follow-up care
Clinical pearls and expert tips for exam success
Updates for 2026:
- Updated to align with the 2026/2027 academic year and latest clinical guidelines
- Revised to include recent hypertension management protocols (e.g., ACC/AHA guidelines)
- Enhanced rationales with current evidence-based practice references
- Added new questions reflecting common exam pitfalls and high-yield concepts
- Incorporated feedback from top-scoring students to refine answer explanations
Abstract:
This exam preparation document is an indispensable resource for graduate nursing students in the NRNP 6512
course, focusing on a comprehensive case study of a 57-year-old patient with high blood pressure. The document
provides a structured approach to conducting a complete health history and physical examination, formulating
differential diagnoses, and developing a holistic management plan. It emphasizes the integration of evidence-based
guidelines, patient-centered care, and interprofessional collaboration. With 200 verified questions, the content
covers essential topics such as cardiovascular risk assessment, diagnostic testing, pharmacological therapies,
lifestyle modifications, and follow-up strategies. Each question is accompanied by detailed rationales that explain
correct and incorrect options, facilitating deep understanding and retention. This resource is updated for the
2026/2027 academic year, ensuring alignment with current standards and best practices. It is designed to help
students achieve a perfect score on the actual exam by reinforcing critical thinking and clinical reasoning skills.
Keywords:
NRNP 6512, Comprehensive Case Study, High Blood Pressure, Hypertension Management, Health History and
Physical, Diagnosis and Management Plan, Exam Prep 2026/2027
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct, along with
explanations for why the other options are incorrect. Rationales reference current clinical guidelines and
evidence-based practice, ensuring a thorough understanding of the underlying concepts.
Compliance Checklist:
Page 1
, Aligned with NRNP 6512 course objectives and exam blueprint
Updated per latest clinical practice guidelines (2026/2027)
Verified by subject matter experts and top-scoring students
Includes rationales for all answers to enhance learning
Formatted for easy navigation and study efficiency
Content Area Overview:
Content Area Questions Key Topics Weight
Health History and Physical 1-40 Chief complaint, history of present illness, 20%
Examination past medical history, review of systems,
vital signs, physical exam findings
Diagnostic Testing and 41-80 Laboratory tests, ECG, imaging, risk 20%
Assessment stratification, differential diagnosis
Pharmacological Management 81-120 Antihypertensive drug classes, dosing, side 20%
effects, drug interactions, treatment
algorithms
Non-Pharmacological 121-160 Dietary approaches (DASH), exercise, 20%
Interventions and Lifestyle weight management, sodium restriction,
Modifications alcohol moderation, smoking cessation
Patient Education, Follow-Up, 161-200 Patient counseling, adherence, monitoring, 20%
and Complications follow-up intervals, hypertensive crisis,
target organ damage
Page 2
,Q1. A 57-year-old patient presents with a blood pressure of 158/96 mmHg on three
separate occasions. The patient has no known comorbidities and a 10-year
atherosclerotic cardiovascular disease (ASCVD) risk of 7.5%. According to the 2017
ACC/AHA hypertension guideline, what is the most appropriate initial management
strategy?
A. Initiate two first-line antihypertensive agents from different classes, with lifestyle
modification.
B. Initiate a thiazide diuretic and reassess in 4 weeks.
C. Prescribe lifestyle modification alone and recheck blood pressure in 3-6 months.
D. Start an ACE inhibitor and add a calcium channel blocker if blood pressure remains
uncontrolled after 1 month.
Correct Answer: C. Prescribe lifestyle modification alone and recheck blood pressure
in 3-6 months.
Rationale: The patient has stage 1 hypertension (130-139/80-89 mmHg) with a 10-year
ASCVD risk <10%. The 2017 ACC/AHA guideline recommends lifestyle modification
alone for such patients, with reassessment in 3-6 months. Pharmacotherapy is
recommended if blood pressure remains elevated after this trial. Initiating two agents or
immediate pharmacotherapy is reserved for stage 2 hypertension or ASCVD risk 10%.
Why Wrong:
A - Two-drug initial therapy is recommended only for stage 2 hypertension or when
blood pressure is >20/10 mmHg above goal, which is not the case here.
B - Thiazide monotherapy is an option, but for stage 1 hypertension with low ASCVD
risk, lifestyle modification is preferred before starting medication.
D - While ACE inhibitors and calcium channel blockers are first-line, immediate
initiation is not indicated for stage 1 hypertension with low risk; lifestyle modification
is the first step.
Reference: Whelton, P.K. et al. (2018). 2017 ACC/AHA Hypertension Guideline.
Hypertension, 71(6), e13-e115.
Q2. Which pathophysiologic mechanism best explains the development of
hypertensive nephrosclerosis in a patient with long-standing uncontrolled
hypertension?
A. Hyperfiltration-induced glomerular hypertrophy leading to podocyte effacement and
proteinuria.
B. Chronic ischemia from arteriolar narrowing and hyaline deposition causing
glomerular scarring.
C. Immune complex deposition in the mesangium triggering inflammatory injury.
D. Tubulointerstitial fibrosis secondary to uric acid crystal deposition.
Correct Answer: B. Chronic ischemia from arteriolar narrowing and hyaline
Page 3
, deposition causing glomerular scarring.
Rationale: Hypertensive nephrosclerosis results from chronic elevated pressure causing
arteriolar hyalinosis and intimal thickening, leading to ischemic glomerular damage and
eventual scarring. This is the classic mechanism. Hyperfiltration (A) is more characteristic
of early diabetic nephropathy. Immune complex deposition (C) is seen in
glomerulonephritis, and uric acid deposition (D) is associated with gouty nephropathy.
Why Wrong:
A - Hyperfiltration and podocyte changes are more typical of diabetic nephropathy,
not hypertensive nephrosclerosis.
C - Immune complex deposition is a feature of immune-mediated glomerulonephritis,
not hypertension.
D - Uric acid crystal deposition is associated with chronic gout, not a primary
consequence of hypertension.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2021). Robbins & Cotran Pathologic
Basis of Disease, 10th Ed., Ch. 11.
Q3. A patient with resistant hypertension is being evaluated. Which finding on
physical examination most strongly suggests a secondary cause that would alter
management?
A. Auscultatory bruit over the mid-abdomen radiating laterally.
B. A body mass index of 32 kg/m² with acanthosis nigricans.
C. Presence of an S4 heart sound on cardiac auscultation.
D. Bilateral non-pitting edema of the lower extremities.
Correct Answer: A. Auscultatory bruit over the mid-abdomen radiating laterally.
Rationale: An abdominal bruit, especially with lateral radiation, is a classic sign of renal
artery stenosis, a secondary cause of hypertension that requires specific management (e.g.,
revascularization or medical therapy with ACE inhibitors/ARBs). Obesity (B) is a
contributing factor but not a secondary cause requiring different diagnostic workup. S4
(C) is a sign of left ventricular hypertrophy, a consequence of hypertension. Non-pitting
edema (D) suggests lymphedema or thyroid disease, not directly a secondary cause of
hypertension.
Why Wrong:
B - Obesity is a risk factor for hypertension but not a secondary cause that changes
diagnostic evaluation.
C - S4 indicates diastolic dysfunction from chronic hypertension, not a secondary
cause.
D - Non-pitting edema is not characteristic of a secondary cause of hypertension; it
may indicate other systemic conditions.
Reference: Carey, R.M. et al. (2018). Resistant Hypertension: Detection, Evaluation, and
Management. Hypertension, 72(5), e53-e90.
Page 4
Document | 2026/2027 Edition | 200 Verified Questions
NRNP 6512 Week 7 Comprehensive Case Study: 57-Year-Old Patient with High Blood Pressure - 2026-2027
Questions and Answers Already Graded A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for advanced practice
nursing students enrolled in NRNP 6512. It focuses on a detailed case study of a 57-year-old patient
presenting with high blood pressure, encompassing the complete Health History and Physical (H&P),
differential diagnosis, and a comprehensive management plan. With 200 verified questions, this
resource mirrors the actual exam format and content, ensuring students are thoroughly prepared to
achieve a 100% expert score. Updated for the 2026/2027 academic year, it reflects the latest clinical
guidelines and best practices in primary care.
Key Features:
Complete Health History and Physical (H&P) documentation
Differential diagnosis and diagnostic reasoning
Evidence-based management plan for hypertension
Pharmacological and non-pharmacological interventions
Patient education and follow-up care
Clinical pearls and expert tips for exam success
Updates for 2026:
- Updated to align with the 2026/2027 academic year and latest clinical guidelines
- Revised to include recent hypertension management protocols (e.g., ACC/AHA guidelines)
- Enhanced rationales with current evidence-based practice references
- Added new questions reflecting common exam pitfalls and high-yield concepts
- Incorporated feedback from top-scoring students to refine answer explanations
Abstract:
This exam preparation document is an indispensable resource for graduate nursing students in the NRNP 6512
course, focusing on a comprehensive case study of a 57-year-old patient with high blood pressure. The document
provides a structured approach to conducting a complete health history and physical examination, formulating
differential diagnoses, and developing a holistic management plan. It emphasizes the integration of evidence-based
guidelines, patient-centered care, and interprofessional collaboration. With 200 verified questions, the content
covers essential topics such as cardiovascular risk assessment, diagnostic testing, pharmacological therapies,
lifestyle modifications, and follow-up strategies. Each question is accompanied by detailed rationales that explain
correct and incorrect options, facilitating deep understanding and retention. This resource is updated for the
2026/2027 academic year, ensuring alignment with current standards and best practices. It is designed to help
students achieve a perfect score on the actual exam by reinforcing critical thinking and clinical reasoning skills.
Keywords:
NRNP 6512, Comprehensive Case Study, High Blood Pressure, Hypertension Management, Health History and
Physical, Diagnosis and Management Plan, Exam Prep 2026/2027
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct, along with
explanations for why the other options are incorrect. Rationales reference current clinical guidelines and
evidence-based practice, ensuring a thorough understanding of the underlying concepts.
Compliance Checklist:
Page 1
, Aligned with NRNP 6512 course objectives and exam blueprint
Updated per latest clinical practice guidelines (2026/2027)
Verified by subject matter experts and top-scoring students
Includes rationales for all answers to enhance learning
Formatted for easy navigation and study efficiency
Content Area Overview:
Content Area Questions Key Topics Weight
Health History and Physical 1-40 Chief complaint, history of present illness, 20%
Examination past medical history, review of systems,
vital signs, physical exam findings
Diagnostic Testing and 41-80 Laboratory tests, ECG, imaging, risk 20%
Assessment stratification, differential diagnosis
Pharmacological Management 81-120 Antihypertensive drug classes, dosing, side 20%
effects, drug interactions, treatment
algorithms
Non-Pharmacological 121-160 Dietary approaches (DASH), exercise, 20%
Interventions and Lifestyle weight management, sodium restriction,
Modifications alcohol moderation, smoking cessation
Patient Education, Follow-Up, 161-200 Patient counseling, adherence, monitoring, 20%
and Complications follow-up intervals, hypertensive crisis,
target organ damage
Page 2
,Q1. A 57-year-old patient presents with a blood pressure of 158/96 mmHg on three
separate occasions. The patient has no known comorbidities and a 10-year
atherosclerotic cardiovascular disease (ASCVD) risk of 7.5%. According to the 2017
ACC/AHA hypertension guideline, what is the most appropriate initial management
strategy?
A. Initiate two first-line antihypertensive agents from different classes, with lifestyle
modification.
B. Initiate a thiazide diuretic and reassess in 4 weeks.
C. Prescribe lifestyle modification alone and recheck blood pressure in 3-6 months.
D. Start an ACE inhibitor and add a calcium channel blocker if blood pressure remains
uncontrolled after 1 month.
Correct Answer: C. Prescribe lifestyle modification alone and recheck blood pressure
in 3-6 months.
Rationale: The patient has stage 1 hypertension (130-139/80-89 mmHg) with a 10-year
ASCVD risk <10%. The 2017 ACC/AHA guideline recommends lifestyle modification
alone for such patients, with reassessment in 3-6 months. Pharmacotherapy is
recommended if blood pressure remains elevated after this trial. Initiating two agents or
immediate pharmacotherapy is reserved for stage 2 hypertension or ASCVD risk 10%.
Why Wrong:
A - Two-drug initial therapy is recommended only for stage 2 hypertension or when
blood pressure is >20/10 mmHg above goal, which is not the case here.
B - Thiazide monotherapy is an option, but for stage 1 hypertension with low ASCVD
risk, lifestyle modification is preferred before starting medication.
D - While ACE inhibitors and calcium channel blockers are first-line, immediate
initiation is not indicated for stage 1 hypertension with low risk; lifestyle modification
is the first step.
Reference: Whelton, P.K. et al. (2018). 2017 ACC/AHA Hypertension Guideline.
Hypertension, 71(6), e13-e115.
Q2. Which pathophysiologic mechanism best explains the development of
hypertensive nephrosclerosis in a patient with long-standing uncontrolled
hypertension?
A. Hyperfiltration-induced glomerular hypertrophy leading to podocyte effacement and
proteinuria.
B. Chronic ischemia from arteriolar narrowing and hyaline deposition causing
glomerular scarring.
C. Immune complex deposition in the mesangium triggering inflammatory injury.
D. Tubulointerstitial fibrosis secondary to uric acid crystal deposition.
Correct Answer: B. Chronic ischemia from arteriolar narrowing and hyaline
Page 3
, deposition causing glomerular scarring.
Rationale: Hypertensive nephrosclerosis results from chronic elevated pressure causing
arteriolar hyalinosis and intimal thickening, leading to ischemic glomerular damage and
eventual scarring. This is the classic mechanism. Hyperfiltration (A) is more characteristic
of early diabetic nephropathy. Immune complex deposition (C) is seen in
glomerulonephritis, and uric acid deposition (D) is associated with gouty nephropathy.
Why Wrong:
A - Hyperfiltration and podocyte changes are more typical of diabetic nephropathy,
not hypertensive nephrosclerosis.
C - Immune complex deposition is a feature of immune-mediated glomerulonephritis,
not hypertension.
D - Uric acid crystal deposition is associated with chronic gout, not a primary
consequence of hypertension.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2021). Robbins & Cotran Pathologic
Basis of Disease, 10th Ed., Ch. 11.
Q3. A patient with resistant hypertension is being evaluated. Which finding on
physical examination most strongly suggests a secondary cause that would alter
management?
A. Auscultatory bruit over the mid-abdomen radiating laterally.
B. A body mass index of 32 kg/m² with acanthosis nigricans.
C. Presence of an S4 heart sound on cardiac auscultation.
D. Bilateral non-pitting edema of the lower extremities.
Correct Answer: A. Auscultatory bruit over the mid-abdomen radiating laterally.
Rationale: An abdominal bruit, especially with lateral radiation, is a classic sign of renal
artery stenosis, a secondary cause of hypertension that requires specific management (e.g.,
revascularization or medical therapy with ACE inhibitors/ARBs). Obesity (B) is a
contributing factor but not a secondary cause requiring different diagnostic workup. S4
(C) is a sign of left ventricular hypertrophy, a consequence of hypertension. Non-pitting
edema (D) suggests lymphedema or thyroid disease, not directly a secondary cause of
hypertension.
Why Wrong:
B - Obesity is a risk factor for hypertension but not a secondary cause that changes
diagnostic evaluation.
C - S4 indicates diastolic dysfunction from chronic hypertension, not a secondary
cause.
D - Non-pitting edema is not characteristic of a secondary cause of hypertension; it
may indicate other systemic conditions.
Reference: Carey, R.M. et al. (2018). Resistant Hypertension: Detection, Evaluation, and
Management. Hypertension, 72(5), e53-e90.
Page 4
